Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FAVYD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,012
Award facts
- Contract value 100% obligated
- $15,011.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $15,011.50 to DMS Pharmaceutical Group Inc. for the supply of XELJANZ XR 11 mg tablets in units of 30 on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order was issued without a set-aside designation and will be performed at a location in Conshohocken, Pennsylvania. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, specializes in distributing a comprehensive range of pharmaceutical products to federal agencies and military healthcare facilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026. The parent contract, executed under the SPE2DB program, enables DLA to procure an extensive portfolio of pharmaceutical items including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare needs worldwide. DMS Pharmaceutical Group has demonstrated consistent success in competing for federal pharmaceutical contracts and maintains a robust track record of delivering specialized medical products across various therapeutic categories to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FAVYD?
SPE2DB25FAVYD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 7, 2025.
How much is contract SPE2DB25FAVYD worth?
The government has obligated $15,012 on SPE2DB25FAVYD.
Is contract SPE2DB25FAVYD an order under another contract?
Yes. SPE2DB25FAVYD is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAVYD competed?
The extent of competition for SPE2DB25FAVYD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award